Monitor for updates on the strategic process involving ART100 monetization; this order provides validation and could enhance deal terms. The reference from NYU Langone may attract additional hospital customers or acquirers.
Price Chart
Executive Summary
Inspira Technologies received a $580,000 commercial purchase order from NYU Langone Hospital for its FDA-cleared ART100 blood circulation systems, following a multi-patient clinical evaluation. The order provides a key reference for ongoing strategic discussions to monetize the ART100 platform and medical assets.
Key Financial Metrics
Key Facts
- $580,000 commercial purchase order from NYU Langone Hospital for ART100 systems
- Order follows successful clinical evaluation in over 30 patients
- NYU Langone is a top-ranked academic medical center; provides strong reference for commercial discussions
- Company is engaged in an active strategic process to potentially monetize the ART100 platform and other medical assets
Financial Impact
$580,000 commercial order for a $17M market cap company; modest but meaningful for a small-cap
Risk Factors
- Order is relatively small ($580k) and may not lead to significant recurring revenue
- Strategic process may not result in favorable monetization outcomes
- Company has a history of negative T+20 alpha (avg -5.35% vs SPY), suggesting market skepticism
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3296515 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 29, 2026 18w ago | Press Release | $3.07 $1.61 | ▼ −47.56% | ▼ −45.76% | — |
May 18, 2026 19w ago | Press Release | $0.3723 $1.29 | ▲ +245.15% | ▲ +243.57% | — |
May 11, 2026 20w ago | Press Release | $0.4070 $1.60 | ▲ +293.12% | ▲ +293.42% | — |
May 1, 2026 22w ago | Press Release | $0.4680 $3.07 | ▲ +555.98% | ▲ +550.70% | — |
Apr 16, 2026 24w ago | Press Release | $0.4950 $0.4050 | ▼ −18.18% | ▼ −24.00% | — |
Apr 14, 2026 24w ago | Press Release | $0.4750 $0.4070 | ▼ −14.32% | ▼ −20.61% | — |
Apr 13, 2026 24w ago | Press Release | $0.5080 $0.4070 | ▼ −19.88% | ▼ −27.61% | — |
Apr 6, 2026 25w ago | Press Release | $0.4110 $0.4780 | ▲ +16.30% | ▲ +7.32% | — |
Apr 6, 2026 25w ago | Press Release | $0.4110 $0.4780 | ▲ +16.30% | ▲ +7.32% | — |
Mar 31, 2026 26w ago | Press Release | $0.4470 $0.4787 | ▲ +7.09% | ▼ −2.33% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access